Narrative review discusses targeting ferroptosis and cuproptosis in oral squamous cell carcinoma.

This narrative review examines the concept of targeting ferroptosis and cuproptosis for the treatment of oral squamous cell carcinoma. The scope of the article focuses on these specific cellular death pathways as potential therapeutic targets for this condition. No specific study population, sample size, or setting was reported for the evidence presented in this commentary.

The authors discuss the intervention of targeting ferroptosis and cuproptosis without providing a comparator group or primary outcome data. Consequently, no specific results, effect sizes, or follow-up durations are available to support clinical recommendations based on this source. The review does not report any secondary outcomes or adverse event rates.

Limitations of this narrative approach include the absence of quantitative data and the lack of reported funding or conflicts of interest. The practice relevance is not explicitly defined by the authors, and the certainty of any clinical benefit remains unquantified. Clinicians should interpret these mechanistic discussions as theoretical possibilities rather than established treatment standards.